γ-Aminobutyric acid infusion in substantia nigra pars reticulata in rats inhibits ascorbate release in ipsilateral striatum

Neuroscience Letters

Volumn 280, Issue 3, 2000, Pages 191-194

  Christensen, John C ^a   Wang, Zhongrui ^a   Rebec, George V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Ascorbate; Glutamate; Striatum; Substantia nigra; Voltammetry; aminobutyric acid

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ASCORBIC ACID; PICROTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CORPUS STRIATUM; GABAERGIC SYSTEM; MALE; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ASCORBIC ACID; CORPUS STRIATUM; FUNCTIONAL LATERALITY; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INFUSIONS, PARENTERAL; MALE; PICROTOXIN; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0033954394     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00777-1     Document Type: Article

References (20)

1. Basse-Tomusk A., Rebec G.V. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacol. Biochem. Behav. 35:1990;55-60.
2. Bigelow J.C., Brown D.S., Wightman R.M. γ-Aminobutyric acid stimulates the release of endogenous ascorbic acid from rat striatal tissue. J. Neurochem. 42:1984;412-419.
3. Barbieto L., Girault J.A., Godeheu G., Pittaluga A., Glowinski J., Cheramy A. Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: an in vivo release study. Neuroscience. 28:1989;365-374.
4. Clemens J.A., Phebus L.A. Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anesthetized vs unanesthetized rats. Brain Res. 267:1983;183-186.
5. Desole M.S., Anania V., Esposito G., Carboni F., Senini A., Miele E. Neurochemical and behavioral changes induced by ascorbic acid and d-amphetamine in the rat. Pharmacol. Res. Commun. 19:1987;441-450.
6. Desole M.S., Miele M., Enrico P., Fresu L., Esposito G., Denatale G., Miele E. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat. Neurosci. Lett. 139:1992;29-33.
7. Gonon F., Buda M., Cespuglio R., Jouvet M., Pujol J.F. In vivo electrochemical detection of catechols in the neostriatum of anesthetized rats: dopamine or DOPAC? Nature. 286:1980;902-904.
8. Gonon F., Buda M., Cespuglio R., Jouvet M., Pujol J.F. Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid. Brain Res. 223:1981;69-80.
9. Gulley J.M., Rebec G.V. Modulatory effects of ascorbate, alone or with haloperidol, on a lever-release conditioned avoidance response task. Pharmacol. Biochem. Behav. 63:1999;125-129.
10. Kamata K., Wilson R.L., Alloway K.D., Rebec G.V. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. Brain Res. 362:1986;331-338.
11. Kiyatkin E.A., Rebec G.V. Ascorbate modulates glutamate-induced excitations of striatal neurons. Brain Res. 812:1998;14-22.
12. O'Neill R.D., Fillenz M., Sundstrom L., Rawlins J.N.P. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosc. Lett. 52:1984;227-233.
13. Pierce R.C., Rebec G.V. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via non-dopaminergic mechanisms. J. Neurosci. 13:1993;4272-4280.
14. Pierce R.C., Clemens A.J., Grabner C.P., Rebec G.V. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-corticoneostriatal loop. J. Neurochem. 63:1994;1499-1507.
15. Rebec G.V., Pierce R.C. A vitamin as neuromodulator: ascorbate release in the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43:1994;537-565.
16. Schenk J.O., Miller E., Gaddis R., Adams R.N. Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res. 253:1982;353-356.
17. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 86:1998;353-387.
18. Tepper J.M., Martin L.P., Anderson D.R. GABA(A) receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15:1995;3092-3103.
19. Wilson R.L., Wightman R.M. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat. Brain Res. 339:1985;219-226.
20. Wilson R.L., Kamata K., Bigelow J.C., Rebec G.V., Wightman R.M. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum. Brain Res. 370:1986;393-396.